Stock Footage0:11
Getty Images

Dolly shot of Using microscope,note down the book

Pre-K - Higher Ed
Dolly shot of Student use microscope working in Laboratory,Experimental results and note down the book
Stock Footage0:13
Getty Images

cells

Pre-K - Higher Ed
cells
News Clip0:57
Sky News

UK: Scientists at Liverpool School of Tropical Medicine testing samples of Covid-19

Higher Ed
CLEAN: Interior shots of scientists working in a high security laboratory at Liverpools school of tropical medicine testing Covid-19 samples and looking for antibodies on 31st March 2020 Liverpool, United Kingdom.
News Clip3:00
Press Association

Not all coronavirus tests are the same - Which one is right for you?

Higher Ed
Across the world mass testing of Covid-19 is being carried out as a tool to control the spread of the virus. The tests vary and are used to determine if someone has a current or past infection. Here's a guide to the types of tests out...
News Clip3:04
Curated Video

Some Are Calling Monoclonal Antibodies "A Game Changer"

Higher Ed
They were already used for the treatment of other illnesses, but when the pandemic started companies developed them to fight the coronavirus.
News Clip3:45
Bloomberg

100 Million Vaccinations Target an Uphill Battle: Johns Hopkins

Higher Ed
Jan.14 -- Johns Hopkins University Professor of Nursing Jason Farley discusses early trial information on the J&J Covid-19 vaccine and explains the process behind delivering and administering vaccinations. He speaks on "Bloomberg...
News Clip6:51
Bloomberg

Eli Lilly Antibody Drug Will Reduce Hospitalizations: CEO

Higher Ed
Nov.10 -- Eli Lilly & Co. Chairman and Chief Executive Officer David Ricks discusses the drugmaker's Covid-19 antibody therapy bamlanivimab, which was recently granted an emergency-use authorization by the U.S. Food and Drug...
News Clip0:51
Curated Video

A Lab-Created Antibody Could Be First To Beat COVID-19

Higher Ed
Researchers say the antibody, called 47D11, neutralized and killed the coronavirus in a lab setting.
News Clip0:51
Curated Video

A Lab-Created Antibody Could Be First To Beat COVID-19

Higher Ed
Researchers say the antibody, called 47D11, neutralized and killed the coronavirus in a lab setting.
News Clip2:09
Curated Video

Antibody Treatments Boosted By President Trump Are Going Unused

Higher Ed
Monoclonal antibody drugs like Regeneron's cocktail, could help fight the virus, but thousands of doses haven't been touched.
News Clip0:25
Curated Video

Spain Allows Rapid Antibody Test In Pharmacies

Higher Ed
Spain will start offering rapid COVID-19 antibody tests in pharmacies.
News Clip2:09
Curated Video

Analyst: Antibodies don't always mean virus immunity

Higher Ed
The former leader of the Global Rapid Response Team at the Centers for Disease Control and Prevention said serologic (antibody) testing for COVID-19 does not always mean "immunity."
News Clip4:34
Bloomberg

Centivax Antibodies Aim to Combat Covid-19 Variants: CEO

Higher Ed
Jan.25 -- Centivax CEO Jacob Glanville discusses the company’s antibody treatment for Covid-19 with the goal of making the pandemic a “manageable infectious disease.” He speaks with Bloomberg’s David Westin on "Bloomberg Markets:...
News Clip7:11
Bloomberg

Future Vaccines Have 'High Barrier' to Cross, Vir CEO Says

Higher Ed
Dec.04 -- Vir Biotechnology Inc. Chief Executive Officer George Scangos says the manufacturing of vaccines is a highly regulated, complex process and the capacity to make drugs for Covid-19 is "somewhat limited." He speaks on "Bloomberg...
Instructional Video2:09
Curated Video

Analyst: Antibodies don't always mean virus immunity

Higher Ed
The former leader of the Global Rapid Response Team at the Centers for Disease Control and Prevention said serologic (antibody) testing for COVID-19 does not always mean "immunity."
News Clip13:12
Bloomberg

Moderna Says New Vaccine Protects Against Two Covid Strains

Higher Ed
Jan.25 -- Moderna Inc. said its vaccine will protect against two known variants of the Covid-19 vaccine, but it plans to start human studies of a booster shot for a strain from South Africa that may cause immunity to wane more quickly....
News Clip4:44
Press Association

Interview with Professor Roberts encourages plasma donations

Higher Ed
Interview with Professor David Roberts on new plasma trials for the NHS to help fight coronavirus, as they call for more volunteers to come forward to donate.
News Clip0:30
Curated Video

Eli Lilly Pulls The Plug On Antibody Study

Higher Ed
The National Institute of Allergy and Infectious Diseases, which sponsored the study, pulled the plug Monday.
News Clip2:40
Bloomberg

Coronavirus: The Long, Slow Process to Finding a Vaccine

Higher Ed
Mar.02 -- Imperial College London Professor of Virus Genomics Paul Kellam explains the process of researching and developing a vaccine to combat a virus. He speaks with Bloomberg’s Tom Keene on "Bloomberg Surveillance."
News Clip7:42
Bloomberg

Lilly Aims to Produce 100K Covid-19 Antibody Doses by Year End: CFO

Higher Ed
Jul.30 -- Eli Lilly Chief Financial Officer Joshua Smiley says the drugmaker expects to start registratrion trials of its coronavirus antibody treatment "within the next few weeks" and to produce 100,000 doses of a successful therapeutic...
News Clip1:11
Curated Video

CDC Says Virus Antibody Tests Can Be Inaccurate Nearly Half The Time

Higher Ed
The agency is recommending that antibody tests with "high specificity" be used to reduce the chance of false positive results.
News Clip4:16
Press Association

PM: We're being led by scientific advice on coronavirus

Higher Ed
Boris Johnson says that local regions should follow the advice of Chief Medical Officer Chris Whitty in containing the coronavirus. The Prime Minister announced the funding during a tour of a Bedfordshire laboratory, where British...
News Clip7:51
Bloomberg

Novartis CEO ‘Cautiously Optimistic’ on Covid Impact in Fourth Quarter

Higher Ed
Oct.27 -- Novartis Chief Executive Officer Vas Narasimhan discusses the business impact of Covid-19, the race for a vaccine, and the company’s development of a coronavirus antibody treatment. He speaks on "Bloomberg Markets: European Open."
News Clip10:22
Bloomberg

Will Vaccines Protect Us From All Covid-19 Variants?

Higher Ed
Apr.19 -- Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed...